US09062X1037
US09062X1037
Biogen Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 33.35B EUR | 31.91B EUR | 27.06B EUR | 25.84B EUR |
Enterprise Value | 39.34B EUR | 38.98B EUR | 30.24B EUR | 29.4B EUR |
Valuation Multiples | ||||
Trailing P/E | 40.09x | 38.24x | 19.72x | 24.55x |
Forward P/E | 13.65x | -- | -- | -- |
Price to Sales | 3.33x | 3.18x | 2.72x | 3.46x |
Price to Book | 1.77x | 1.69x | 1.45x | 1.42x |
EV/Revenue | 3.92x | 3.89x | 3.04x | 3.94x |
EV/EBITDA | 11.71x | 13.26x | 9.24x | 11.43x |
Price to FCF (P/FCF) | 26.32x | 12.82x | 11.68x | 14.7x |
EV/FCF | 31.05x | 15.66x | 13.05x | 16.74x |
FCF Yield | 3.8% | 7.8% | 8.56% | 6.8% |